Will Morton[email protected]Nuclear MedicineBone marrow disorders associated with SARs in Lutathera patientsPretreatment bone marrow disorders may predict which patients are at risk for severe adverse reactions (SARs) when treated with lutetium-177 DOTATATE.July 15, 2024Radiation Oncology/TherapyRisk factor for blood disorders identified in PRRT patientsResearchers have identified a risk factor that may be involved in potentially fatal blood disorders in patients undergoing peptide receptor radionuclide therapy (PRRT).July 12, 2024Molecular ImagingNew CMS plan adds Medicare coverage of PET imaging agentsThe CMS proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m.July 10, 2024Digital X-RayAI improves evaluations of knee osteoarthritis on x-raysA commercially available AI algorithm improved the performance of junior radiologists when grading knee osteoarthritis on x-rays.July 9, 2024Molecular ImagingLAFOV PET/CT feasible in infants with neuroblastomaLong axial field-of-view (LAFOV) PET/CT scanners offer shorter procedure times and avoid the need for sedation or general anesthesia when imaging young children with neuroblastoma.July 9, 2024Molecular ImagingSwiss team produces 1st 3D PET/MRI imageResearchers at the University of Zurich in Switzerland say they have produced the first cinematically rendered image from a patient based on a standard clinical F-18 FDG-PET/MRI scan.July 5, 2024Molecular ImagingShine CEO: Chrysalis to be world’s largest medical isotope producerGreg Piefer, PhD, founder and CEO of Shine Technologies, says the company is two years away from launching world’s largest medical isotope facility.July 3, 2024Molecular ImagingFDG-PET/CT improves management of patients with head and neck cancerFDG-PET/CT imaging can reduce unnecessary surgeries in patients to remove residual neck cancer after they have undergone chemoradiotherapy.July 2, 2024Molecular ImagingPSMA-PET superior to MRI in phase II prostate cancer trialPET/CT imaging with a new radiotracer is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer.July 1, 20242024Treatment paradigm shifting for men with prostate cancerNew imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC).June 28, 2024Previous PagePage 23 of 50Next PageTop StoriesDigital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputationsLower limb amputation is an increasingly common major complication of advanced peripheral arterial disease and diabetes mellitus.MRI3D MRI technique helps plan treatment for pediatric heart conditionsWomens ImagingCould AI scoring help with managing DCIS?CTClinicians, beware: CT diagnostic accuracy varies by adnexal lesion typePractice ManagementRadiology coding update for 2026